BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33629296)

  • 1. Prognostic role of immunohistochemical overexpression of the p16 protein in women under the age of 35 and diagnosed with HSIL (CIN2) subjected to "cervix sparing" excision.
    Lukic A; Rossi S; Frega A; Ruscito I; Bianchi P; Nobili F; Caserta D; Vecchione A
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1261-1273. PubMed ID: 33629296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
    Castle PE; Adcock R; Cuzick J; Wentzensen N; Torrez-Martinez NE; Torres SM; Stoler MH; Ronnett BM; Joste NE; Darragh TM; Gravitt PE; Schiffman M; Hunt WC; Kinney WK; Wheeler CM; ;
    Arch Pathol Lab Med; 2020 Jun; 144(6):725-734. PubMed ID: 31718233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of p16
    Miralpeix E; Genovés J; Maria Solé-Sedeño J; Mancebo G; Lloveras B; Bellosillo B; Alameda F; Carreras R
    Mod Pathol; 2017 Feb; 30(2):304-310. PubMed ID: 27739439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
    Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
    Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of Precancerous Cervical Lesion Predicted by p16 Protein Immunohistochemistry in Rajavithi Hospital.
    Charoonwatana T; Boonlikit S; Yanaranop M
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1809-1815. PubMed ID: 31244304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of p16(INK4a) and Ki-67 Immunohistochemical Staining in Cervical Intraepithelial Neoplasia Grade 2 Biopsies as Biomarkers for Cervical Intraepithelial Neoplasia Grade 3 in Cone Results.
    Miralpeix E; Solé-Sedeño JM; Mancebo G; Lloveras B; Bellosillo B; Carreras R; Alameda F
    Anal Quant Cytopathol Histpathol; 2016 Feb; 38(1):1-8. PubMed ID: 27363060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study.
    Ciavattini A; Serri M; Di Giuseppe J; Liverani CA; Gardella B; Papiccio M; Delli Carpini G; Morini S; Clemente N; Sopracordevole F
    BMJ Open; 2019 Jul; 9(7):e024920. PubMed ID: 31272971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of HPV 16/18 Genotyping and p16/Ki-67 Dual Staining to Predict Progression to HSIL/CIN2+ in Negative Cytologies From a Colposcopy Referral Population.
    Rodríguez-Trujillo A; Martí C; Angeles MA; Sierra A; Esteve R; Saco A; Barnadas E; Marimón L; Nicolás I; Torné A; Ordi J; Del Pino M
    Am J Clin Pathol; 2018 Oct; 150(5):432-440. PubMed ID: 30052715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
    Byun SW; Lee A; Kim S; Choi YJ; Lee YS; Park JS
    Int J Med Sci; 2013; 10(12):1602-7. PubMed ID: 24151431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential influence of p16 immunohistochemical staining on the diagnosis of squamous cell lesions in cervical biopsy specimens: observation from cytologic-histologic correlation.
    Yang J; Elliott A; Hoffa AL; Herring N; Houser PM
    Cancer Cytopathol; 2018 Dec; 126(12):1003-1010. PubMed ID: 30307707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
    White C; Bakhiet S; Bates M; Keegan H; Pilkington L; Ruttle C; Sharp L; O' Toole S; Fitzpatrick M; Flannelly G; O' Leary JJ; Martin CM
    Cytopathology; 2016 Aug; 27(4):269-76. PubMed ID: 26932360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix.
    Sagasta A; Castillo P; Saco A; Torné A; Esteve R; Marimon L; Ordi J; Del Pino M
    Mod Pathol; 2016 Jan; 29(1):51-9. PubMed ID: 26541274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
    Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
    Shain AF; Kwok S; Folkins AK; Kong CS
    Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of p16/Ki-67 dual staining in the detection of cervical precancer and cancer in China.
    Zhang SK; Jia MM; Zhao DM; Wu ZN; Guo Z; Liu YL; Guo PP; Chen Q; Cao XQ; Liu SZ; Chen W; Sun XB
    Cancer Epidemiol; 2019 Apr; 59():123-128. PubMed ID: 30739069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P16 immunostaining and HPV testing in histological specimens from the uterine cervix.
    Capobianco G; Marras V; Wenger JM; Santeufemia DA; Ambrosini G; Lutzoni R; Dessole M; Cherchi PL
    Eur J Gynaecol Oncol; 2013; 34(3):227-30. PubMed ID: 23967551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions.
    Leeman A; Jenkins D; Del Pino M; Ordi J; Torné A; Doorbar J; Meijer CJLM; van Kemenade FJ; Quint WGV
    Cancer Med; 2020 Apr; 9(7):2454-2461. PubMed ID: 32022461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.